Pfizer Inc. 13D and 13G filings for Akero Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:19 pm Unchanged | 2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO | PFIZER INC PFE | 2,525,252 4.530% | 0 (Unchanged) | Filing |
| 2022-06-28 4:19 pm Purchase | 2022-06-17 | 13G | Akero Therapeutics, Inc. AKRO | PFIZER INC PFE | 2,525,252 6.700% | 2,525,252 (New Position) | Filing |